Insulin icodec, which will be sold under the brand name Awiqli, is the first once-a-week basal insulin injection in the world and it will be available across the country starting June 30.
We do not want to stop medications that are safely helping to treat symptoms, but we could think about ‘legacy prescriptions’ which people may have been taking for many years without re-evaluation.
St. John’s medical resident, Dr. Etienne Archambault, who also discussed the use of the medications to support athletics, has been ordered to pay a fine.